Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis

Ng, Benjamin, Dong, Jinrui, D’Agostino, Giuseppe, Viswanathan, Sivakumar, Widjaja, Anissa A., Lim, Wei-Wen, Ko, Nicole S. J., Tan, Jessie +14 more·2019·Science Translational Medicine

DOI 10.1126/scitranslmed.aaw1237

Cited by (311)

Items 101–200 of 311

Myostatin as a fibroblast‐activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma
Sachiyo Yoshio, Tomonari Shimagaki, Ryuki Hashida, Takumi Kawaguchi, Yuriko Tsutsui, Yuzuru Sakamoto, Yuichi Yoshida, Hironari Kawai, Shiori Yoshikawa, Taiji Yamazoe et al. · 2021 · Hepatology Research
C-MYC induces idiopathic pulmonary fibrosis via modulation of miR-9-5p-mediated TBPL1
Hui Qin, Yan Tang, Yuan Mao, Xuehui Zhou, Tongrong Xu, Wenming Liu, Xin Su · 2022 · Cellular Signalling
Autologous Skin Fibroblast‐Based PLGA Nanoparticles for Treating Multiorgan Fibrosis
Qiang Long, Zehua Liu, Qianwen Shao, Hongpeng Shi, Shixing Huang, Chenyu Jiang, Bei Qian, Yiming Zhong, Xiaojun He, Xiaogang Xiang et al. · 2022 · Advanced Science
Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases
Jana Zarubova, Xuexiang Zhang, Tyler Hoffman, Mohammad Mahdi Hasani‐Sadrabadi, Song Li · 2021 · Matter
Ophiocordyceps lanpingensis polysaccharides attenuate pulmonary fibrosis in mice
Shubo Zhou, Yongchun Zhou, Jiaji Yu, Yaxi Du, Yong Tan, K E Ying-Mei, Juan Wang, Benyong Han, Feng Ge · 2020 · Biomedicine & Pharmacotherapy
CCL17 drives fibroblast activation in the progression of pulmonary fibrosis by enhancing the TGF-β/Smad signaling
Qian-rong Wang, Suo-si Liu, Jiali Min, Min Yin, Yan Zhang, Yu Zhang, Xiang-ning Tang, Xia Li, Shanshan Liu · 2023 · Biochemical Pharmacology
Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown
Ulrich Blache, Stefania L. Wunderli, Amro A. Hussien, Tino Stauber, Gabriel Flückiger, Maja Bollhalder, Barbara Niederöst, Sandro F. Fucentese, Jess Gerrit Snedeker · 2021 · Scientific Reports
The Transcriptional Landscape of Pericytes in Acute Ischemic Stroke
Carolina Buizza, Andreas Enström, R. Carlsson, Gesine Paul · 2023 · Translational Stroke Research
Cardiomyocyte-Restricted Expression of IL11 Causes Cardiac Fibrosis, Inflammation, and Dysfunction
Mark D. Sweeney, Katie O’Fee, Chelsie Villanueva-Hayes, Ekhlas Rahman, Michael Lee, Konstantinos Vanezis, Ivan Andrew, Wei‐Wen Lim, Anissa Anindya Widjaja, Paul J.R. Barton et al. · 2023 · International Journal of Molecular Sciences
Therapeutic Targeting of IL-11 for Chronic Lung Disease
Rosa K. Kortekaas, Janette Kay Burgess, Roël van Orsoy, David J. Lamb, Megan J. Webster, Reinoud Gosens · 2021 · Trends in Pharmacological Sciences
Modeling of lung phenotype of Hermansky–Pudlak syndrome type I using patient-specific iPSCs
Takahiro Suezawa, Shuhei Kanagaki, Yohei Korogi, Kazuhisa Nakao, Toyohiro Hirai, Koji Murakami, Masatoshi Hagiwara, Shimpei Gotoh · 2021 · Respiratory Research
Biomimetic lipid Nanocomplexes incorporating STAT3-inhibiting peptides effectively infiltrate the lung barrier and ameliorate pulmonary fibrosis
Hyeongseop Keum, Jinjoo Kim, Dohyun Yoo, Tae Woo Kim, Changjin Seo, Dohyeon Kim, Sangyong Jon · 2021 · Journal of Controlled Release
Fibroblast-derived interleukin-6 exacerbates adverse cardiac remodeling after myocardial infarction
Hongkun Li, Yunfei Bian · 2024 · Korean Journal of Physiology and Pharmacology
Roles of IL-11 in the regulation of bone metabolism
Yijing Han, Hui Gao, Xinling Gan, Jingying Liu, Chuncha Bao, Chengqi He · 2024 · Frontiers in Endocrinology
Decoding the mosaic of inflammatory bowel disease: Illuminating insights with single-cell RNA technology
Liang Liu, Benjamin Davidorf, Peixian Dong, Alice Peng, Qianqian Song, Zhiheng He · 2024 · Computational and Structural Biotechnology Journal
Interleukin-11 causes alveolar type 2 cell dysfunction and prevents alveolar regeneration
Benjamin Ng, Kevin Y. Huang, Chee Jian Pua, Sivakumar Viswanathan, Wei‐Wen Lim, Fathima F Kuthubudeen, Yu‐Ning Liu, An An Hii, Benjamin L. George, Anissa Anindya Widjaja et al. · 2024 · Nature Communications
Current evidence on the role of fibroblasts in large-vessel vasculitides: From pathogenesis to therapeutics
Shuang Xu, William Febry Jiemy, Elisabeth Brouwer, Janette Kay Burgess, Peter Heeringa, Kornelis S. M. van der Geest, Roser Alba-Rovira, Marc Corbera‐Bellalta, Annemieke M. H. Boots, Maria Cinta Cid et al. · 2024 · Autoimmunity Reviews
Advances in engineered nanosystems: immunomodulatory interactions for therapeutic applications
Rupam Khatua, Bibrita Bhar, Souradeep Dey, Chitra Jaiswal, Jorge I. Victoria, Biman B. Mandal · 2024 · Nanoscale
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–6
Jean Jacques Vanden Eynde, Arduino Aleksander Mangoni, Jarkko Rautio, Jérôme Leprince, Yasu‐Taka Azuma, Alfonso T. García‐Sosa, Christopher Hulme, Josef Jampílek, Rafik Karaman, Wěi Li et al. · 2019 · Molecules
Inhalable nucleic acid therapeutics for chronic pulmonary disease: Progress, challenges, and prospects
Yangeng Wang, Wenzhe Xuan, Chengqiong Mao, Yang Liu · 2025 · Acta Biomaterialia
Interleukin-11 disrupts alveolar epithelial progenitor function
Rosa K. Kortekaas, Kerstin E. Geillinger‐Kästle, Theo Borghuis, Kaoutar Belharch, Megan J. Webster, Wim Timens, Janette Kay Burgess, Reinoud Gosens · 2023 · ERJ Open Research
Therapeutic Targeting of Interleukin-11 Signalling Reduces Pressure Overload–Induced Cardiac Fibrosis in Mice
Ben Corden, Wei‐Wen Lim, Weihua Song, Chen Xie, Nicole S. J. Ko, Liping Su, Nicole Tee, Eleonora Adami, Sebastian Schäfer, Stuart A. Cook · 2020 · Journal of Cardiovascular Translational Research
Inhibition of a signaling modality within the gp130 receptor enhances tissue regeneration and mitigates osteoarthritis
Ruzanna Shkhyan, Candace Flynn, Emma Lamoure, Arijita Sarkar, Benjamin Van Handel, Jinxiu Li, Jesse York, Nicholas W. Banks, Robert A. van der Horst, Nancy Q. Liu et al. · 2023 · Science Translational Medicine
Leukemia inhibitory factor (LIF) receptor amplifies pathogenic activation of fibroblasts in lung fibrosis
Hung N. Nguyen, Yunju Jeong, Yunhye Kim, Mari Kamiya, Y. Kim, Humra Athar, Peter J. Castaldi, Craig P. Hersh, Jaivardhan A. Menon, Jessie Wong et al. · 2024 · Proceedings of the National Academy of Sciences
Revisiting pulmonary fibrosis: inflammatory dynamics of the lipofibroblast-to-inflammatory lipofibroblast-to-activated myofibroblast reversible switch
Georgios‐Dimitrios Panagiotidis, Esmeralda Vásquez‐Pacheco, Xuran Chu, Werner Seeger, Elie El Agha, Savério Bellusci, Arun Lingampally · 2025 · Frontiers in Immunology
Genome-wide DNA methylation analysis of pulmonary function in middle and old-aged Chinese monozygotic twins
Tong Wang, Weijing Wang, Weilong Li, Haiping Duan, Chunsheng Xu, Xiaocao Tian, Dongfeng Zhang · 2021 · Respiratory Research
4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition
Yaxian Wu, Yaru Zhang, Fengjuan Jiang, Shuai He, Yanli Zhang, Dan Chen, Ying Tong, Yunjuan Nie, Qingfeng Pang · 2023 · Inflammation Research
Cytokine signaling converging on IL11 in ILD fibroblasts provokes aberrant epithelial differentiation signatures
Miriam T. Kastlmeier, E. González González, Phoebe Cabanis, Eva M. Guenther, Ann‐Christine König, Lianyong Han, Stefanie M. Hauck, Fenja See, Sara Asgharpour, Christina Bukas et al. · 2023 · Frontiers in Immunology
Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis
Su Yeon An, Anca Daniela Petrescu, Sharon DeMorrow · 2021 · Frontiers in Pharmacology
Vascular involvement in idiopathic pulmonary fibrosis
Michele Mondoni, Rocco Francesco Rinaldo, Christopher J. Ryerson, Cristina Albrici, Andrea Baccelli, Claudio Tirelli, Francesca Marchetti, Jacopo Cefalo, Giulia Nalesso, Giulia Ferranti et al. · 2024 · ERJ Open Research
MicroRNA‑375 prevents TGF‑β‑dependent transdifferentiation of lung fibroblasts via the MAP2K6/P38 pathway
Xinghua Zhang, Qian Chen, Hengya Song, Wanli Jiang, Songping Xie, Jie Huang, Ganjun Kang · 2020 · Molecular Medicine Reports
In vitro mechanical vibration down-regulates pro-inflammatory and pro-fibrotic signaling in human vocal fold fibroblasts
David Hortobagyi, Tanja Grossmann, Magdalena Tschernitz, Magdalena Grill, Andrijana Kirsch, Claus Gerstenberger, Markus Gugatschka · 2020 · PLoS ONE
Genome-Wide RNA Sequencing of Human Trabecular Meshwork Cells Treated with TGF-β1: Relevance to Pseudoexfoliation Glaucoma
Anton W. Roodnat, Breedge Callaghan, Chelsey Doyle, Megan Henry, Katarzyna Goljanek‐Whysall, David A. C. Simpson, Carl Sheridan, Sarah D. Atkinson, Colin Eric Willoughby · 2022 · Biomolecules
Elevated interleukin‐11 in systemic sclerosis and role in disease pathogenesis
Thomas Steadman, Steven O'Reilly · 2023 · The Journal of Dermatology
Neutralization of interleukin-11 attenuates silica particles-induced pulmonary inflammation and fibrosis in vivo
Jixuan Ma, Yujia Xie, Yiju Xu, Pei Hua Gu, Yingdie Zhang, Lieyang Fan, Yun Zhou, Haijiao Wang, Ting Zhou, Jintong He et al. · 2022 · Journal of Environmental Sciences
SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling
Blanca D. López‐Ayllón, Ana de Lucas‐Rius, Laura Mendoza‐García, Tránsito García‐García, Raúl Fernández‐Rodríguez, José M. Suárez-Cárdenas, Fátima Milhano Santos, Fernando José Corrales, Natalia Redondo, Federica Pedrucci et al. · 2023 · Frontiers in Immunology
Senotherapy for chronic lung disease
Peter John Barnes · 2025 · Pharmacological Reviews
Anti-Inflammatory and Anti-Fibrotic Effect of Immortalized Mesenchymal-Stem-Cell-Derived Conditioned Medium on Human Lung Myofibroblasts and Epithelial Cells
Eirini Filidou, Leonidas Kandilogiannakis, Gesthimani Tarapatzi, Michail Spathakis, Paschalis Steiropoulos, Dimitrios A. Mikroulis, Konstantinos I. Arvanitidis, Vasilis Paspaliaris, George C. Kolios · 2022 · International Journal of Molecular Sciences
IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβ
Yunhao Tan, Kenta Mosallanejad, Qingxiu C. Zhang, Stephen O’Brien, Meghan E. Clements, Stuart J. Perper, Sarah S. Wilson, Sudiksha Chaulagain, Jing Wang, Mary Abdalla et al. · 2024 · Frontiers in Immunology
Antibody‐mediated neutralization of IL11 signalling reduces ERK activation and cardiac fibrosis in a mouse model of severe pressure overload
Wei‐Wen Lim, Ben Corden, Lei Ye, Sivakumar Viswanathan, Anissa Anindya Widjaja, Chen Xie, Liping Su, Nicole Tee, Sebastian Schäfer, Stuart A. Cook · 2021 · Clinical and Experimental Pharmacology and Physiology
Cardiac and Renal Fibrosis, the Silent Killer in the Cardiovascular Continuum: An Up-to-Date
Traian Chiuariu, Delia Lidia Șalaru, Carina Ureche, Laura Catalina Tapoi, Ancuța Lupu, Vasile Valeriu Lupu, Adela Mihaela Șerban, Alexandra Zăvoi, Laura-Cătălina Benchea, Alexandra Clément et al. · 2024 · Journal of Cardiovascular Development and Disease
Krüppel‐Like Factor 15/Interleukin 11 Axis‐Mediated Adventitial Remodeling Depends on Extracellular Signal‐Regulated Kinases 1 and 2 Activation in Angiotensin II–Induced Hypertension
Yuetong Guo, Yuanyuan Lu, Xiao Lu, Shun He, Shijin Li, Shuai Shao, Han‐Dan Zhou, Ruiqi L. Wang, Xiaodong Li, Pingjin Gao · 2021 · Journal of the American Heart Association
Cellular senescence in adult pulmonary hypertension: current state and future challenges
Sarah-Eve S Lemay, Yukimitsu Kuwabara, Sébastien Bonnet, François Potus, Steeve Provencher, Serge Adnot, Olivier Boucherat · 2025 · European Respiratory Review
Investigation of a UPR-Related Gene Signature Identifies the Pro-Fibrotic Effects of Thrombospondin-1 by Activating CD47/ROS/Endoplasmic Reticulum Stress Pathway in Lung Fibroblasts
Junhui Zhan, Juan Wei, Lin Liu, Yi‐Tong Xu, Hui Ji, Chang-Nan Wang, Yujian Liu, Xiaoyan Zhu · 2023 · Antioxidants
TRIOBP modulates β-catenin signaling by regulation of miR-29b in idiopathic pulmonary fibrosis
Lan Wang, Wenyu Zhao, Cong Xia, Shuaichen Ma, Zhongzheng Li, Ningdan Wang, Linke Ding, Yaxuan Wang, L C Cheng, Huibing Liu et al. · 2023 · Cellular and Molecular Life Sciences
Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine
Ali Fatehi Hassanabad, Anna N. Zarzycki, Paul W.M. Fedak · 2024 · Cardiovascular Pathology
Interleukin-11 drives fibroblast metabolic reprogramming in crystalline silica-induced lung fibrosis
Yujia Xie, Shiyu Yang, Yiju Xu, Pei Hua Gu, Yingdie Zhang, Xiaojie You, Haoyu Yin, Bingxin Shang, Yuxin Yao, Wei Li et al. · 2024 · The Science of The Total Environment
Harnessing the regenerative potential of interleukin11 to enhance heart repair
Kwangdeok Shin, Anjelica Rodriguez, Chanul Kim, Isabella M. Silaban, Yu Xia, Jisheng Sun, Chenyang Dong, Sündüz Keleş, Jinhu Wang, Jingli Cao et al. · 2024 · Nature Communications
IL-11/IL-11R signal inhibition by 9MW3811 remodels immune tumor microenvironment and enhances anti-tumor efficacy of PD-1 blockade
Chang Zhang, Shasha Jiao, Dadi Zeng, Wen G. Jiang, Rongjuan Wang, Bin Zheng, Min Wang, Shuang Wang, Xun Gui · 2025 · npj Precision Oncology
Ameliorative Effects of Osthole on Experimental Renal Fibrosis in vivo and in vitro by Inhibiting IL-11/ERK1/2 Signaling
Fan Wu, Yan Qing Zhao, Qingqing Shao, Ke Fang, Ruolan Dong, Shujun Jiang, Fuer Lu, Jinlong Luo, Guang Chen · 2021 · Frontiers in Pharmacology
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
David Schumacher, Elisa Anamaria Liehn, Pakhwan Nilcham, David Castaño Mayan, Chutima Rattanasopa, Kaviya Anand, Gustavo E Crespo-Avilan, Sauri Hernández‐Reséndiz, Roshni Rebecca Singaraja, Stuart A. Cook et al. · 2021 · Scientific Reports
Metastasis‐associated protein 1 promotes epithelial‐mesenchymal transition in idiopathic pulmonary fibrosis by up‐regulating Snail expression
Weibin Qian, Xinrui Cai, Qiuhai Qian, Wei Zhang, Li Tian · 2020 · Journal of Cellular and Molecular Medicine
Natural products for anti-fibrotic therapy in idiopathic pulmonary fibrosis: marine and terrestrial insights
Meili Ma, Zhengqi Chu, Hongyu Quan, Hua Li, Yuran Zhou, Yanhong Han, Kefeng Li, Wenjun Pan, Deyun Wang, Yan Yan et al. · 2025 · Frontiers in Pharmacology
MEK/ERK/RUNX2 Pathway-Mediated IL-11 Autocrine Promotes the Activation of Müller Glial Cells during Diabetic Retinopathy
Na Ji, Yang Guo, Songbai Liu, Manhui Zhu, Yuanyuan Tu, Jiahui Du, Xiaoxiao Wang, Ying Wang, E Song · 2022 · Current Eye Research
Role of Interleukin-6 Family Cytokines in Organ Fibrosis
Ying Chen, Jiaxin Zhou, Shihui Xu, Jing Nie · 2023 · Kidney Diseases
Biomimetic Topological Micropattern Arrays Regulate the Heterogeneity of Cellular Fates in Lung Fibroblasts between Fibrosis and Invasion
Xinglong Zhu, Shengqiang Mao, Ying Kui Yang, Xinmei Liu, Qin Liu, Ning Zhang, Yongfeng Yang, Yanan Li, Mengyu Gao, Ji Bao et al. · 2025 · ACS Nano
IL11 (Interleukin-11) Causes Emphysematous Lung Disease in a Mouse Model of Marfan Syndrome
Benjamin Ng, Chen Xie, Liping Su, Fathima F Kuthubudeen, Xiu-Yi Kwek, Daryl Yeong, Chee Jian Pua, Stuart A. Cook, Wei‐Wen Lim · 2023 · Arteriosclerosis Thrombosis and Vascular Biology
Polyhexamethylene guanidine phosphate-induced necrosis may be linked to pulmonary fibrosis
Min-Sung Kang, Sunghwan Kim, Mi‐Jin Yang, Hyeon-Young Kim, In-Hyeon Kim, Jeong Won Kang, Hye Sook Choi, Seung-Woo Jin, Eun‐Jung Park · 2022 · Toxicology Letters
Effects of bone morphogenetic protein 4 on TGF- β 1-induced cell proliferation, apoptosis, activation and differentiation in mouse lung fibroblasts via ERK/p38 MAPK signaling pathway
Zhou Cai, Hua Guo, Jing Qian, Wei Qing Liu, Yuanyuan Li, Yuan Liang, You Zhou, Ran Lin, Xiaohui Xie, Qiong Yang et al. · 2022 · PeerJ
The matricellular protein CCN3 supports lung endothelial homeostasis and function
Kalpana R. Betageri, Patrick A. Link, Andrew J. Haak, Giovanni Ligresti, Daniel J. Tschumperlin, Nunzia Caporarello · 2022 · American Journal of Physiology-Lung Cellular and Molecular Physiology
Pirfenidone and nintedanib attenuates pulmonary artery endothelial and smooth muscle cells transformations induced by IL-11
Inés Roger, Paula Montero, Javier Milara, Julio Cortijo · 2024 · European Journal of Pharmacology
Mechanisms and Therapeutic Potential of Myofibroblast Transformation in Pulmonary Fibrosis
Tianming Zhao, Yunchao Su · 2025 · Journal of Respiratory Biology and Translational Medicine
Panax Notoginseng Saponins Regulate Transforming Growth Factor-β1 through MAPK and Snail/TWIST1 Signaling Pathway to Inhibit Epithelial-Mesenchymal Transition of Pulmonary Fibrosis in A549 Cells
Vietdung Nguyen, Fei Pan, Guangzhong Zhang, Qing Zhang, Yang Lu · 2022 · Evidence-based Complementary and Alternative Medicine
The CaMKII Inhibitory Peptide AIP Alleviates Renal Fibrosis Through the TGF-β/Smad and RAF/ERK Pathways
Xiaocui Feng, Jianfeng Zhang, Runling Yang, Jingya Bai, Bochuan Deng, Lu Cheng, Feiyun Gao, Junqiu Xie, Bangzhi Zhang · 2022 · Journal of Pharmacology and Experimental Therapeutics
Spatially discrete signalling niches regulate fibroblast heterogeneity in human lung cancer
Christopher Jon Hanley, Sara Waise, Robert G. Parker, MA Lopez, J Taylor, Lucy Kimbley, Jonathan J. West, Christian H. H. Ottensmeier, Matthew J.J. Rose-Zerilli, Gareth J. Thomas · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Pathogenesis of fibrosis in interstitial lung disease
Olivier Burgy, Pierre‐Simon Bellaye, Guillaume Beltramo, Françoise Goirand, Philippe Bonniaud · 2020 · Current Opinion in Pulmonary Medicine
GSE4‐loaded nanoparticles a potential therapy for lung fibrosis that enhances pneumocyte growth, reduces apoptosis and DNA damage
Laura Pintado‐Berninches, Ana Montes‐Worboys, Cristina Manguán-García, Elena G. Arias‐Salgado, Adela Serrano, Beatriz Fernández-Varas, Rosa Guerrero, Laura Iarriccio, Lurdes Planas‐Cerezales, Guillermo Güenechea et al. · 2021 · The FASEB Journal
Emerging roles for IL-6 family cytokines as positive and negative regulators of ectopic lymphoid structures
David Gregory Hill, Amy Ward, Lindsay B. Nicholson, Gareth Wyn Jones · 2021 · Cytokine
Blockade of IL-11 Trans-Signaling or JAK2/STAT3 Signaling Ameliorates the Profibrotic Effect of IL-11
Wenjing Ye, Qian Wang, Li Zhao, Changcheng Wang, Dandan Zhang, Mengyu Zhou, Fangfang Chen, Weiguo Wang, Zaihua Zhu, Wenyu Guo et al. · 2023 · Immunological Investigations
FLUOROFENIDONE ATTENUATES PULMONARY INFLAMMATION AND FIBROSIS BY INHIBITING THE IL-11/MEK/ERK SIGNALING PATHWAY
Cheng Song, Xiaofan Liu, Weijun Tan, Xiaoqun Guo, Yahui Mao, Qi Zhou, Shuang Geng, Yi Hu · 2022 · Shock
Aging-associated interleukin-11 drives the molecular mechanism and targeted therapy of idiopathic pulmonary fibrosis
Jing Zhou, Xing An, Xiuwen Xia, Wei Xiao, Dou Ding, Weihong Li, Qingsong Huang · 2025 · European journal of medical research
Interleukin-11: A central integrative hub driving pathological progression from pulmonary inflammation and fibrosis to cancer
Jinglu Yu, Jialong Qi, Xiaoni Kong, Yu Feng · 2025 · Pharmacological Research
Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy
Scott A. Bowler, Chathura Siriwardhana, Breeana L. Mitchell, Michelle L. D’Antoni, Debra Ogata-Arakaki, Scott A. Souza, Raymond K. Yee, Louie Mar A. Gangcuangco, Dominic Cheung Chow, Lishomwa C. Ndhlovu et al. · 2019 · HIV Research & Clinical Practice
Gremlin2 Activates Fibroblasts to Promote Pulmonary Fibrosis Through the Bone Morphogenic Protein Pathway
Caijuan Huan, Wangting Xu, Yaru Liu, Kexin Ruan, Yueli Shi, Hongqiang Cheng, Xue Zhi Zhang, Yuehai Ke, Jianying Zhou · 2021 · Frontiers in Molecular Biosciences
Interleukin-11 Is Elevated in Patients with Atrial Fibrillation, Correlates with Serum Fibrosis Markers, and Represents a Therapeutic Target for Atrial Fibrosis
Xinpeng Cong, Bei Tian, Xi Zhu, Xiaogang Zhang, Wei Gu, Hanjun Zhao, Shuwen Hao, Zhongping Ning · 2023 · Cerebrovascular Diseases
IL-11 drives the phenotypic transformation of tracheal epithelial cells and fibroblasts to enhance abnormal repair after tracheal injury
Rui Xiao, Lei Gu, An-mao Li, Yiling Gan, Chun-yan He, Jiaxin Liao, Yishi Li, Li Xu, Shuliang Guo · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Targeting IL-11 system as a treatment of pulmonary arterial hypertension
Javier Milara, Inés Roger, Paula Montero, Enrique Artigues, Juan Escrivá, Francisco Pérez‐Vizcaíno, Julio Cortijo · 2023 · Pharmacological Research
Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis
Ce Li, Zhenzi Peng, Yizhou Wang, Gloria Lam, Nicholas N. Nissen, Jie Tang, Xiaopu Yuan, Michael S. Lewis, Mark Irwin Greene, Stephen Jacob Pandol et al. · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Epithelial–mesenchymal transition in chemoradiation‐induced lung damage: Mechanisms and potential treatment approaches
Mohamed J. Saadh, Pawan Sharma, Israa Habeeb Naser, Abhishek Kumar, M. Ravi Kumar, Irodakhon Rasulova, Faraj Mohammed, Omer Qutaiba B. Allela, Wathiq Kh. Mohammed, Nayyrah Ahmed et al. · 2024 · Journal of Biochemical and Molecular Toxicology
FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma
Junshang Ge, Ying Liu, Pan Chen, Zhaoyang Zeng, Guiyuan Li, Wei Xiong, Mei Yi, Bo Xiang · 2024 · Journal for ImmunoTherapy of Cancer
Roles and mechanism of IL-11 in vascular diseases
Jiacheng Wu, Wenrui Ma, Zhihua Qiu, Zihua Zhou · 2023 · Frontiers in Cardiovascular Medicine
Emerging therapeutic targets in systemic sclerosis
Steven O’Reilly · 2024 · Journal of Molecular Medicine
Current strategies and opportunities to manufacture cells for modeling human lungs
Ratna Varma, John P. Soleas, Thomas K. Waddell, Golnaz Karoubi, Alison P. McGuigan · 2020 · Advanced Drug Delivery Reviews
Induction of interleukin-11 mediated by RhoA GTPase during human cytomegalovirus lytic infection
Saud A. Alarifi, Saad Hussin Alkahtani, Ahmed Ali Al-Qahtani, Christos Stournaras, George Sourvinos · 2020 · Cellular Signalling
Critical Conditions for Studying Interleukin‐11 Signaling In Vitro and Avoiding Experimental Artefacts
Sivakumar Viswanathan, Benjamin Ng, Anissa Anindya Widjaja, Chee Jian Pua, Nevin Tham, Jessie Tan, Stuart A. Cook, Sebastian Schäfer · 2021 · Current Protocols
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–7
Michael Gütschow, Jean Jacques Vanden Eynde, Josef Jampílek, CongBao Kang, Arduino Aleksander Mangoni, Paola Fossa, Rafik Karaman, Andrea Trabocchi, Peter J. H. Scott, Jóhannes Reynisson et al. · 2020 · Molecules
Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic
Maria Myzithras, Siqi Lin, Legairre Radden, Cynthia Hess Kenny, Zheng Cai, Angus MacDonald, Ralph Binetti, Michael Marlow, Paul Fracasso, Glenn R. Gibson et al. · 2022 · mAbs
The Influence of IL-11 on Cardiac Fibrosis in Experimental Models: A Systematic Review
Yarlla Loyane Lira Braga, José Rodrigues do Carmo Neto, Pablo Igor Ribeiro Franco, Fernanda Rodrígues Helmo, Marlene Antônia dos Reis, Flávia Aparecida de Oliveira, Mara Rúbia Nunes Celes, Marcos Vinicius da Silva, Juliana Reis Machado · 2024 · Journal of Cardiovascular Development and Disease
Suppression of the TGF-β pathway by a macrolide antibiotic decreases fibrotic responses by ocular fibroblasts in vitro
Thomas Stahnke, Beata Gajda-Deryło, Anselm G. Jünemann, Oliver Stachs, Katharina Anna Sterenczak, Robert Ręjdak, Julia Beck, Ekkehard Schütz, Steffen Möller, Israel Barrantes et al. · 2020 · Royal Society Open Science
Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation
Toru Arai, Masaki Hirose, Tomoko Kagawa, Kazuyoshi Hatsuda, Yoshikazu Inoue · 2023 · Journal of Thoracic Disease
Commensal microbiome dysbiosis elicits interleukin-8 signaling to drive fibrotic skin disease
Wenyu Zhang, Qili Peng, Xian Huang, Qing Huang, Zhiliang Zhang, Fuli Li, Naisheng Zheng, Binsheng Shi, Zhihong Fan, Tomasz Maj et al. · 2024 · PNAS Nexus
Lung-Targeting Perylenediimide Nanocomposites for Efficient Therapy of Idiopathic Pulmonary Fibrosis
Yuting Liu, Damin Xu, Xiaoyi Xing, Anqi Shen, Xinpeng Jin, Shijiao Li, Zhonghua Liu, Liming Wang, Yongwei Huang · 2024 · Nano Letters
Advances in Interleukin-6 Family Cytokines and the Role in Respiratory Diseases
Tuo Ji, Guanhong Huang, Yudie Cao, Yuzhi Gao, Xuzhu Gao · 2025 · Journal of Inflammation Research
Emerging Therapeutic Strategies in Anti‐Aging Medicine: A Comprehensive Review
Yundong Peng, Rui Li, Huan Li, Jun Zhou, Xuanshi Liu, Guilherme Targino Valente, Tatiana de Campos Melo, Sifan Chen, 顾镭 · 2026 · Medicine Bulletin
Potential Role of Macrophage Polarization in the Progression of Hunner-Type Interstitial Cystitis
Kwang Jin Ko, Gahyun Kim, Hyun Hwan Sung, Woong‐Yang Park, Kyu‐Sung Lee · 2024 · International Journal of Molecular Sciences
Fatty acid synthase inhibition alleviates lung fibrosis via β-catenin signal in fibroblasts
Hui Lian, Yujie Zhang, Zhao Zhu, Ruyan Wan, Zhixia Wang, Kun Jin Yang, Shuaichen Ma, Yaxuan Wang, Kai Xu, L C Cheng et al. · 2024 · Life Science Alliance
TRPA1: A promising target for pulmonary fibrosis?
Chao Li, Jiawen Xu, Aliya Abdurehim, Qing Sun, Junbo Xie, Yanqing Zhang · 2023 · European Journal of Pharmacology
Illuminating the pathogenic role of SARS-CoV-2: Insights into competing endogenous RNAs (ceRNAs) regulatory networks
Mahsa Aghajani Mir · 2024 · Infection Genetics and Evolution
Site-specific dimerization of interleukin-11 alleviates bleomycin-induced pulmonary fibrosis in mice
Sa Wang, Pengyu Wang, Xiaotong Song, Xinyuan Ma, Long Wei, Yongxiang Zheng, Rong Yu, Chun Zhang · 2024 · European Journal of Pharmaceutical Sciences
Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis
Meng Wang, Andong Liu, Qian Niu, Xiao Feng, Yuanyi Zheng, Shuai-Jun Chen, Hui Min Xu, Qian Li, Guoqing Hou, Xiaoyang Bi et al. · 2022 · Theranostics